✦ LIBER ✦

Resistance-Associated Variants in Chronic Hepatitis C Patients Treated with Protease Inhibitors

✍ Scribed by Maya Gambarin-Gelwan; Ira M. Jacobson

Book ID: 107539678
Publisher: Springer
Year: 2011
Tongue: English
Weight: 149 KB
Volume: 14
Category: Article
ISSN: 1522-8037
DOI: 10.1007/s11894-011-0237-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis C: Antici

Treatment of chronic hepatitis C: Anticipated impact of resistance in patients treated with protease inhibitors

✍ Bernd Kronenberger; Stefan Zeuzem 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 432 KB

Mutations in hepatitis C virus NS3 prote

Mutations in hepatitis C virus NS3 protease domain associated with resistance to specific protease inhibitors in antiviral therapy naïve patients

✍ Allan Peres-da-Silva; Adilson José de Almeida; Elisabeth Lampe 📂 Article 📅 2010 🏛 Springer Vienna 🌐 English ⚖ 458 KB

Insulin resistance is associated with st

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C

✍ Calogero Cammà; Savino Bruno; Vito Di Marco; Danilo Di Bona; Mariagrazia Rumi; M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Conflicting data exist regarding the relationship between hepatitis C virus genotype 1 and hepatic steatosis as well as the latter's role in the progression of fibrosis and treatment response. We assessed factors associated with hepatic steatosis in genotype 1 chronic hepatitis C and the impact of h

Frequent detection of hepatitis B virus

Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes

✍ S. Gloria Selabe; Ernest Song; Rosemary J. Burnett; M. Jeffrey Mphahlele 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Abstract This retrospective study investigated and characterized the YMDD motif of the hepatitis B virus (HBV) reverse transcriptase (RT) gene, in sequential samples of 17 South African patients with chronic hepatitis B infection on lamivudine treatment. The profile of HBV genotypes as well as t

Efficacy and safety of telaprevir, a new

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C

✍ N. Hayashi; T. Okanoue; H. Tsubouchi; J. Toyota; K. Chayama; H. Kumada 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Characterization of resistance to the pr

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients

✍ Simone Susser; Christoph Welsch; Yalan Wang; Markus Zettler; Francisco S. Doming 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

Boceprevir is a hepatitis C virus (HCV) nonstructural protein (NS) 3/4A protease inhibitor that is currently being evaluated in combination with peginterferon alfa-2b and ribavirin in phase 3 studies. The clinical resistance profile of boceprevir is not characterized in detail so far. The NS3 protea